Citation Impact
Citing Papers
Minimum sample size for developing a multivariable prediction model: PART II ‐ binary and time‐to‐event outcomes
2018
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
2013 Standout
Validation of a clinical prognostic model to identify low‐risk patients with pulmonary embolism
2007
The validation and reproducibility of the pulmonary embolism severity index
2010
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Evolution of untreated calf deep-vein thrombosis in high risk symptomatic outpatients: The blind, prospective CALTHRO study
2010
Simplification of the Diagnostic Management of Suspected Deep Vein Thrombosis
2002
Methodologic Standards for the Development of Clinical Decision Rules in Emergency Medicine
1999
Validity of a Set of Clinical Criteria to Rule Out Injury to the Cervical Spine in Patients with Blunt Trauma
2000 Standout
Development of Diagnostic Criteria for Serious Non-AIDS Events in HIV Clinical Trials
2010
Ambulatory management of pulmonary embolism: a pragmatic evaluation
2010
Evaluation of D-Dimer in the Diagnosis of Suspected Deep-Vein Thrombosis
2003 Standout
Contribution of platelets to tumour metastasis
2011 Standout
Anti-cancer properties of low-molecular-weight heparin: Preclinical evidence
2009
Management of primary care patients with suspected deep vein thrombosis: use of a therapeutic dose of low‐molecular‐weight heparin to avoid urgent ultrasonographic evaluation
2006
Perioperative Management of Antithrombotic Therapy
2012 Standout
D-dimer testing as an adjunct to ultrasonography in patients with clinically suspected deep vein thrombosis: prospective cohort study
1998
Safety of outpatient treatment in acute pulmonary embolism
2010
Neither baseline tests of molecular hypercoagulability nor D-dimer levels predict deep venous thrombosis in critically ill medical-surgical patients
2004
Risk factors and clinical impact of postoperative symptomatic venous thromboembolism
2007
Multidetector Computed Tomography for Acute Pulmonary Embolism
2006 Standout
Emergency Hospitalizations for Adverse Drug Events in Older Americans
2011 Standout
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
2015 Standout
Patient follow-up after negative lower extremity bedside ultrasound for deep venous thrombosis in the ED
2006
Effect of prolonged treatment with compression stockings to prevent post-thrombotic sequelae: A randomized controlled trial
2008
Mobilization versus immobilization in the treatment of acute proximal deep venous thrombosis: a prospective, randomized, open, multicentre trial
2006
Risk of Deep Vein Thrombosis Following a Single Negative Whole-Leg Compression Ultrasound
2010
Deep-vein thrombosis
1999
Periprocedural thromboprophylaxis in patients receiving chronic anticoagulation therapy
2003
Out of hospital treatment of acute pulmonary embolism in patients with a low NT‐proBNP level
2010
Diagnosis of DVT
2012
Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker
2012
Serial 2-Point Ultrasonography Plus D-Dimer vs Whole-Leg Color-Coded Doppler Ultrasonography for Diagnosing Suspected Symptomatic Deep Vein Thrombosis
2008
Pulmonary embolism and deep vein thrombosis
2012
The Canadian C-Spine Rule for Radiography in Alert and Stable Trauma Patients
2001 Standout
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism
2004 Standout
GRADE guidelines: 3. Rating the quality of evidence
2011 Standout
Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation
2007
Type 2 diabetes
2017 Standout
Prevention of venous thromboembolism in spinal surgery
2003
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
2015 Standout
Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency
2005
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Prevention of Venous Thromboembolism
2004 Standout
The Perioperative Management of Antithrombotic Therapy
2008
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Deep venous thrombosis in medical-surgical critically ill patients: Prevalence, incidence, and risk factors
2005
Incidence, risk factors, and treatment patterns for deep venous thrombosis in hospitalized children: An increasing population at risk
2008
Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial
2011
Calculating the sample size required for developing a clinical prediction model
2020 Standout
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
2008 Standout
New anticoagulants: how to deal with treatment failure and bleeding complications
2011
Validation of a clinical algorithm to identify low‐risk patients with pulmonary embolism
2010
Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study
2011
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment
2008
Deep vein thrombosis
2005
Prospective validation of the Pulmonary Embolism Severity Index
2008
Haemodynamically unstable pulmonary embolism in the RIETE Registry: systolic blood pressure or shock index?
2007
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
2013 Standout
Outpatient treatment and early discharge of symptomatic pulmonary embolism: a systematic review
2009
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015 Standout
Frequency of venous thromboembolism in low to moderate risk long distance air travellers: the New Zealand Air Traveller's Thrombosis (NZATT) study
2003
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
2013 Standout
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Practical diagnostic management of patients with clinically suspected deep vein thrombosis by clinical probability test, compression ultrasonography, and D-dimer test
2002
External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges
2016
Derivation and Validation of a Prognostic Model for Pulmonary Embolism
2005
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
A single complete ultrasound investigation of the venous network for the diagnostic management of patients with a clinically suspected first episode of deep venous thrombosis of the lower limbs
2003
Ultrasonography and Diagnosis of Venous Thromboembolism
2004
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
2002 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
A Randomized Trial of Diagnostic Strategies after Normal Proximal Vein Ultrasonography for Suspected Deep Venous Thrombosis: d -Dimer Testing Compared with Repeated Ultrasonography
2005
Validation of a model to predict adverse outcomes in patients with pulmonary embolism
2005
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer
2014
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
2010 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
2014
The Wells Rule Does Not Adequately Rule Out Deep Venous Thrombosis in Primary Care Patients
2005
Oxidative Stress and Diabetic Complications
2010 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Complete compression ultrasonography of the leg veins as a single test for the diagnosis of deep vein thrombosis
2003
Clinical Predictors for Fatal Pulmonary Embolism in 15 520 Patients With Venous Thromboembolism
2008
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Excluding Pulmonary Embolism at the Bedside without Diagnostic Imaging: Management of Patients with Suspected Pulmonary Embolism Presenting to the Emergency Department by Using a Simple Clinical Model and d -dimer
2001 Standout
Noninvasive Diagnosis of Deep Venous Thrombosis
1998
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism
2013 Standout
Meta‐analysis and aggregation of multiple published prediction models
2014
Translating Clinical Research into Clinical Practice: Impact of Using Prediction Rules To Make Decisions
2006
Clinical relevance of distal deep vein thrombosis. Review of literature data.
2006
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement
2015 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Part 8: Adult Advanced Cardiovascular Life Support
2010 Standout
Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
2012 Standout
Withholding Anticoagulation after a Negative Result on Duplex Ultrasonography for Suspected Symptomatic Deep Venous Thrombosis
2004
Prognosis and prognostic research: application and impact of prognostic models in clinical practice
2009
Systematic Review: Case-Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding Events Among Patients Treated for Venous Thromboembolism
2010
Aggregating published prediction models with individual participant data: a comparison of different approaches
2012
Works of Lisa Gray being referenced
A Model for Perioperative Outpatient Management of Anticoagulation in High-Risk Patients: An Evaluation of Effectiveness and Safety
2001
Outpatient treatment of deep vein thrombosis and pulmonary embolism: A hospital-based program
1999
A Randomized Trial Comparing 2 Low-Molecular-Weight Heparins for the Outpatient Treatment of Deep Vein Thrombosis and Pulmonary Embolism
2005
Value of assessment of pretest probability of deep-vein thrombosis in clinical management
1997
Thrombosis in the Emergency Department
1999
Application of a Diagnostic Clinical Model for the Management of Hospitalized Patients with Suspected Deep-vein Thrombosis
1999